Renal Cancer Metastasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-11-09
Clinical Trial Update: A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma [Phase 2]
Phase 2 trial investigating anti-PD-1 combinations of D-CIK immunotherapy with axitinib in metastatic renal cancer.